Parkwood LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,048
Closed -$1.59M 178
2024
Q1
$1.59M Buy
+2,048
New +$1.46M 0.14% 119
2016
Q3
Sell
-47,111
Closed -$3.71M 508
2016
Q2
$3.71M Buy
47,111
+13,574
+40% +$1.02M 0.62% 40
2016
Q1
$2.42M Buy
33,537
+26,073
+349% +$1.97M 0.41% 54
2015
Q4
$629K Hold
7,464
0.1% 156
2015
Q3
$625K Buy
+7,464
New +$630K 0.1% 117
2014
Q1
Sell
-3,705
Closed -$189K 319
2013
Q4
$189K Buy
+3,705
New +$186K 0.05% 211

Other funds holding LLY

Parkwood LLC's LLY Position: Q2 2024 in Review

Parkwood LLC sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 2,048 shares — an estimated $1.59M sold.

Parkwood LLC first reported a position in LLY in Q4 2013 and held it in 6 quarters. The position peaked at $3.71M in Q2 2016. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Parkwood LLC reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Parkwood LLC sold 2,048 Eli Lilly shares in Q2 2024, an estimated $1.59M.
  • Parkwood LLC first reported a position in Eli Lilly in Q4 2013 and held it in 6 quarters.
  • Parkwood LLC's Eli Lilly position peaked at $3.71M in Q2 2016.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Parkwood LLC's 13F filing for Q2 2024, filed 14 Aug 2024.